BioSpace News Archive

Microbiologics Announces New CEO

Microbiologics, a global biotechnology products and services leader, announced today that Kristen Knox has been appointed as Chief Executive Officer (CEO) of the company.

January 31, 2023
·
2 min read
Career Advice

No Ph.D., No Problem: BioPharma Companies Welcome Candidates with Only a Bachelor’s Degree

Now more than ever, there is ample opportunity for life science candidates with only a bachelor’s degree. Still, there are certain things these candidates should know to ensure their success.

January 31, 2023
·
5 min read
·
Hayley Shasteen
Business

Pfizer’s 2023 Projections Reflect End to Emergency COVID-19 Measures

Pfizer reported full-year 2022 earnings Tuesday and provided 2023 projections far below the previous year’s totals.

January 31, 2023
·
1 min read
·
Heather McKenzie
Drug Development

uniQure Gains Rights to Apic’s Gene Therapy for SOD1-ALS

uniQure inked a deal with Apic Bio to gain development and commercialization rights to APB-102, a gene therapy for a rare, genetic form of ALS.

January 31, 2023
·
2 min read
·
Rosemary Scott
BioMidwest

Axion BioSystems Launches New High-Throughput Live-Cell Imaging Platform, Omni Pro 12

Axion BioSystems announces the addition of the Omni Pro 12 to the Omni live-cell imaging product family.

January 31, 2023
·
2 min read
Policy

Occlutech Continues its Progress in US FDA Study OCCLUFLEX – Enrolls First Patient in Europe

Occlutech Holding AG, one of the world’s leading providers of minimally invasive structural heart disease devices, continues its progress in the US market.

January 31, 2023
·
3 min read
Drug Development

Last Patient Included in Alzecure’s Phase II Clinical Trial in Peripheral Neuropathic Pain with The Non-Opioid ACD440

AlzeCure Pharma AB announced that the last patient has now been included in the ongoing Phase II clinical study with ACD440, the lead non-opioid drug candidate in the Painless platform, which is being developed against peripheral neuropathic pain.

January 31, 2023
·
5 min read
Business

Biophytis Publishes its Financial Results for the First Half of 2022

Biophytis SA publishes its interim financial report for the first half of 2022 and its adjusted financial results as of 31 December 2021.

January 31, 2023
·
8 min read
Singleron to present single cell sequencing solutions at the 36th Molecular Biology of Plants Conference

Singleron Biotechnologies, a leader in single cell sequencing, will present at the upcoming 36th Molecular Biology of Plants 2023 Conference of the Section Plant Physiology and Molecular Biology of the German Society for Plant Sciences in Hennef, Germany.

January 31, 2023
·
1 min read
FDA

Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System

Axonics, Inc. today announced that the U.S. Food and Drug Administration has approved the company’s fourth-generation rechargeable sacral neuromodulation system.

January 31, 2023
·
3 min read